Introduction (Article introduction authored by Conquest Editorial Team) A clinical practice guideline (CPG) was developed to provide podiatric recommendations for managing rheumatoid arthritis (RA), focusing on conservative care. The guideline…
Introduction (Article introduction authored by Conquest Editorial Team) A variety of disease-modifying antirheumatic drugs (DMARDs) are now available for treating rheumatoid arthritis (RA), including biologic DMARDs (bDMARDs) such as TNF…
Introduction (Article introduction authored by Conquest Editorial Team) Rheumatoid arthritis (RA) poses a diagnostic challenge due to its diverse clinical manifestations, ranging from polyarthritis to systemic complications. PET/CT imaging, particularly…
Introduction (Article introduction authored by Conquest Editorial Team) In recent years, significant strides have been made in understanding the genetic, environmental, and immunological factors contributing to rheumatoid arthritis (RA). Detection…
Introduction (Article introduction authored by Conquest Editorial Team) Over the past two decades, treatment options for rheumatoid arthritis (RA) have evolved significantly. Methotrexate (MTX), biologic disease-modifying antirheumatic drugs (bDMARDs), and…
Introduction Rheumatoid arthritis (RA) stands as a multifaceted autoimmune disorder marked by persistent inflammation impacting the synovial tissues of numerous joints. Granzymes (Gzms) are serine proteases that are unleashed into…
Introduction Chronic anterior uveitis is a concern in up to 20% of children with juvenile idiopathic arthritis (JIA) and can lead to vision loss. Early detection through regular eye screenings…
Introduction Rheumatoid arthritis (RA) is a chronic and inflammatory autoimmune disease that affects elderly individuals worldwide. Severe cases of RA can lead to long-term disability due to significant damage to…
Introduction Rheumatoid arthritis is an immune disorder that causes joint inflammation and damage, often leading to deformities and disability. Conventional treatments have limitations, but the emergence of antibody drugs offers…
Introduction Janus kinase inhibitors (JAKis) are a class of drugs that differ from biologics in their mechanism of action and are rapidly gaining traction in the field of rheumatology. JAK,…
